Effect of Mirabegron on Intraocular Pressure in Patients with Glaucoma by Emine Şeker Ün, Sıtkı Ün

Subjects: “…mirabegron…”
Get full text

Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs by Nazish Sarfraz, Humera Akram, Afroza Abbas, Sadaf Shaheen, Zoobia Ashiq Awan, Eesha Yaqoob

Subjects: Get full text

Acupuncture combined with mirabegron is efficacious for the treatment of overactive bladder: a prospective randomized controlled trial by Deng Xiaolin, Xie Baoquan, Huang Xin, Kuang Jin, Yao Lei

Subjects: Get full text

Therapeutic efficacy of mirabegron 25 mg monotherapy in patients with nocturia-predominant hypersensitive bladder by Cheng-Ling Lee, Hueih-Ling Ong, Hann-Chorng Kuo

Subjects: Get full text

Drug-induced xerostomia and hyposalivation in patients with overactive bladder: a prospective open-label observational study comparing antimuscarinics and β3-adrenoceptor agonists by Magdalena Ostrowska, Layla Settaf-Cherif, Jan Kiersztyn, Adam Ostrowski, Tomasz A. Drewa, Jan Adamowicz, Maciej J. Wróbel

Subjects: Get full text

Two birds with one stone: sustainable smart spectrophotometric methods for concurrent determination of silodosin and mirabegron: application to dosage forms and greenness assessmen... by Khalid M. Badr El-Din, Sayed M. Derayea, Ahmed S. Ahmed, Mohamed Oraby, Mohamed A. Abdelshakour

Subjects: Get full text

Green HPLC technique development for the simultaneous determination of the potential combination of Mirabegron and Tamsulosin by Eman A. Bahgat, Hanaa Saleh, Islam M. Darwish, Omar M El-Abassy

Subjects: “…Mirabegron…”
Get full text

How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies by Hann-Chorng Kuo

Subjects: Get full text

The efficacy and safety of mirabegron and α-adrenergic receptor antagonist in the treatment of distal ureteral stones: a systematic review and meta-analysis by Yicheng Guo, Fengze Sun, Yini Wang, Yanfei Li, Tianqi Wang, Xiaohong Ma, Jitao Wu

Subjects: “…mirabegron…”
Get full text

Cutting-edge assays for mirabegron and tadalafil combo therapy for benign prostatic hyperplasia; insilico kinetics approach; multi trait sustainability assessment by Sara I. Aboras, Mohamed R. Abdelhakim, Hadir M. Maher, Rasha M. Youssef

Subjects: “…Mirabegron…”
Get full text

Does Mirabegron the β3 Agonist Frequently Used in the Treatment of Overactive Bladder Really Affect the Respiratory System Negatively ? A Prospective Study by Şenol Adanur, Ahmet Gedik, Ömer Araz, Elif Yılmazel Ucar, Kadir Ozmen, Fatih Akkaş, Tugay Aksakalli, Adem Utlu, Ahmet Cinislioğlu

Subjects: Get full text

Eco-friendly spectrophotometric quantification of the potential combination of mirabegron and tamsulosin by Omar M El-Abassy, Hanaa Saleh, Islam M. Darwish, Eman A. Bahgat

Subjects: “…Mirabegron…”
Get full text

Comparative analysis using UPLC and UV methods for concurrent quantification of therapeutic drugs for overactive bladder: Effective approach in green and white chemistry by Asma S. Al-Wasidi, Mahmoud A. Mohamed, Hoda A. Ahmed, Manal A. Almalki, Alaa A. Ahmed-Anwar

Subjects: Get full text

Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder by Jee Soo Park, Won Sik Jang, Jongchan Kim, Moon-Hwa Park, Won Sik Ham

Subjects: Get full text

Sustainable UV approaches backed by one step extraction procedure for quantifying the newly released mirabegron and silodosin mixture in urine by Ahmed R. Mohamed, Sara El‑Hanboushy, Eman Darweish

Subjects: “…Mirabegron…”
Get full text

An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder by Zhipeng Zhang, Deyi Luo, Zhong Chen, Peng Zhang, Ganping Zhong, Keji Xie, Zhuoqun Xu, Xudong Li, Jianye Wang, Yingfan Yang, Farid Abdul Hadi, Arianne Schild

Subjects: Get full text

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose? by Cheng-Ling Lee, Hann-Chorng Kuo

Subjects: Get full text

Mirabegron in the Management of Overactive Bladder Syndrome in Ghazi Al-Hariri Hospital by Hiba H. Razaq, Mohammed B. Ismail, Mohamed E. Abdelrhman

Subjects: Get full text

Effect of β3-adrenergic receptor agonists on [18F] fluorodeoxyglucose uptake in brown adipose tissues in positron emission tomography images of elderly patients by John Kenneth V. Gacula, Kenichiro Ogane, Kaori Fuse, Miyako Morooka Chikanishi, Kimiteru Ito

Subjects: Get full text

Designing a sustained-release solid oral formulation for overactive bladder treatment: a quality by design approach by Neeraj Sharma, Daksh Bhatia, Sharda Shambhakar, Pavitra Solanki

Subjects: Get full text